• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Cangene Corp

YGE:GR

Ticker Delisted

Snapshot for Cangene Corp (YGE)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for YGE

No chart data available.
  • YGE:GR 2.293
  • 1M
  • 1Y
0.000
Interactive YGE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for YGE

Current P/E Ratio (ttm) -
Estimated P/E(07/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (07/2014) -0.0800
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for YGE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for YGE

Cangene Corporation develops, manufactures, and sells biopharmaceutical drugs. The Company produces plasma-derived and recombinant therapeutic proteins used in the prevention of Rh disease and blood clotting deficiencies.

Jeff LamotheChief Financial OfficerGary FloydChief Operating Officer
Laura SawardChief Scientific OfficerFrancis J St HilaireVP/Secretary/General Counsel
More Company Profile & Key Executives for YGE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil